To further evaluate whether miR-27a high-expression was linked to the clinical progression of breast cancer, we analyzed the association of miR-27a and ZBTB10 expression with the clinicopathological status of breast cancer patients (Table 1). This evidence concerns the gene ZBTB10 and breast cancer.